Page last updated: 2024-09-05

sorafenib and Acquired Metabolic Diseases, Brain

sorafenib has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biasco, G; Brandi, G; Calzà, L; Caraceni, P; Cirignotta, F; de Rosa, F; Girolamo, SD; Ricci, CS; Tufoni, M	1

Other Studies

1 other study(ies) available for sorafenib and Acquired Metabolic Diseases, Brain

Article	Year
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:3 Topics: Aged; Brain Diseases, Metabolic; Carcinoma, Hepatocellular; Cognition Disorders; Electroencephalography; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Mood Disorders; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Retrospective Studies; Sorafenib; Treatment Outcome	2013

Article

Year

Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?

Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:3

Topics: Aged; Brain Diseases, Metabolic; Carcinoma, Hepatocellular; Cognition Disorders; Electroencephalography; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Mood Disorders; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Retrospective Studies; Sorafenib; Treatment Outcome

2013